A novel battery of self-administered, smartphone application–based neuroperformance tests would allow more frequent, remote assessments of motor and cognitive function in people with multiple sclerosis.
For a clinical audience, our team’s efforts highlight that usual care looks different across clinics, regions, and countries, which highlights the importance of interpreting the results of trials with usual care comparators carefully.